Michael Paal

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 9

Top Topics

Cystic Fibrosis

Drug Administration

Candida Albicans

Liquid Chromatography Tandem Mass Spectrometry

Top Venues

Clinical chemistry and laboratory medicine

Antibiotics (Basel, Switzerland)

Journal of biophotonics

This page only lists publications with an associated author ORCID identifier.

Publications

Lars Willems, Michael Paal, Michael Vogeser
Transport stability profiling - a proposed generic protocol. Clinical chemistry and laboratory medicine 60 (7) (2022)
Simon Kallee, Christina Scharf, Lea Marie Schatz, Michael Paal, Michael Vogeser, Michael Irlbeck, Johannes Zander, Michael Zoller, Uwe Liebchen
Systematic Evaluation of Voriconazole Pharmacokinetic Models without Pharmacogenetic Information for Bayesian Forecasting in Critically Ill Patients. Pharmaceutics 14 (9) (2022)
Louise Füessl, Tobias Lau, Isaac Lean, Sandra Hasmann, Bernhard Riedl, Florian M Arend, Johanna Sorodoc-Otto, Daniela Soreth-Rieke, Marcell Toepfer, Simon Rau, Haxhrije Salihi-Halimi, Michael Paal, Wilke Beuthien, Norbert Thaller, Yana Suttmann, Gero von Gersdorff, Ron Regenauer, Anke von Bergwelt-Baildon, Daniel Teupser, Mathias Bruegel, Michael Fischereder, Ulf Schönermarck
Diminished Short- and Long-Term Antibody Response after SARS-CoV-2 Vaccination in Hemodialysis Patients. Vaccines 10 (4) (2022)
Katharina Habler, Michael Paal, Felix Lucian Happich, Michael Vogeser
Pitfall in the analysis of the alcohol biomarkers ethyl glucuronide and ethyl sulfate by laboratory-caused contamination with disinfectants. Clinical chemistry and laboratory medicine (2022)
Christian Heckl, Alexander Lang, Adrian Rühm, Ronald Sroka, Thomas Duffield, Michael Vogeser, Michael Paal
Spectrophotometric evaluation of hemolysis in plasma by quantification of free oxyhemoglobin, methemoglobin, and methemalbumin in presence of bilirubin. Journal of biophotonics 14 (5) (2021)
Uwe Liebchen, Sophie Rakete, Michael Vogeser, Florian M Arend, Christina Kinast, Christina Scharf, Michael Zoller, Ulf Schönermarck, Michael Paal
The Role of Non-Enzymatic Degradation of Meropenem-Insights from the Bottle to the Body. Antibiotics (Basel, Switzerland) 10 (6) (2021)
Simon Kallee, Christina Scharf, Ines Schroeder, Michael Paal, Michael Vogeser, Michael Irlbeck, Johannes Zander, Michael Zoller, Jette Jung, Nikolaus Kneidinger, Christian Schneider, Sebastian Michel, Uwe Liebchen
Comparing posaconazole and itraconazole for antifungal prophylaxis in critically ill lung transplant recipients: Efficacy and plasma concentrations. Transplant infectious disease : an official journal of the Transplantation Society 23 (4) (2021)
Katharina Habler, Anne-Sophie Kalla, Michael Rychlik, Mathias Bruegel, Daniel Teupser, Susanne Nährig, Michael Vogeser, Michael Paal
Isotope dilution LC-MS/MS quantification of the cystic fibrosis transmembrane conductance regulator (CFTR) modulators ivacaftor, lumacaftor, tezacaftor, elexacaftor, and their major metabolites in human serum. Clinical chemistry and laboratory medicine 60 (1) (2021)
Uwe Liebchen, Marian Klose, Michael Paal, Michael Vogeser, Michael Zoller, Ines Schroeder, Lisa Schmitt, Wilhelm Huisinga, Robin Michelet, Johannes Zander, Christina Scharf, Ferdinand Anton Weinelt, Charlotte Kloft
Evaluation of the MeroRisk Calculator, A User-Friendly Tool to Predict the Risk of Meropenem Target Non-Attainment in Critically Ill Patients. Antibiotics (Basel, Switzerland) 10 (4) (2021)